Search

Your search keyword '"Shoda, Morio"' showing total 915 results
Start Over Author "Shoda, Morio"
915 results on '"Shoda, Morio"'

3. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.

Author

Chung, Mina, Patton, Kristen, Lau, Chu-Pak, Dal Forno, Alexander, Al-Khatib, Sana, Arora, Vanita, Birgersdotter-Green, Ulrika, Cha, Yong-Mei, Chung, Eugene, Cronin, Edmond, Curtis, Anne, Cygankiewicz, Iwona, Dandamudi, Gopi, Dubin, Anne, Ensch, Douglas, Glotzer, Taya, Gold, Michael, Goldberger, Zachary, Gopinathannair, Rakesh, Gorodeski, Eiran, Gutierrez, Alejandra, Guzman, Juan, Huang, Weijian, Imrey, Peter, Indik, Julia, Karim, Saima, Karpawich, Peter, Khaykin, Yaariv, Kiehl, Erich, Kron, Jordana, Kutyifa, Valentina, Link, Mark, Marine, Joseph, Mullens, Wilfried, Park, Seung-Jung, Parkash, Ratika, Patete, Manuel, Pathak, Rajeev, Perona, Carlos, Rickard, John, Schoenfeld, Mark, Seow, Swee-Chong, Shen, Win-Kuang, Shoda, Morio, Singh, Jagmeet, Slotwiner, David, Sridhar, Arun, Srivatsa, Uma, Stecker, Eric, Tanawuttiwat, Tanyanan, Tang, W, Tapias, Carlos, Tracy, Cynthia, Upadhyay, Gaurav, Varma, Niraj, Vernooy, Kevin, Vijayaraman, Pugazhendhi, Worsnick, Sarah, Zareba, Wojciech, and Zeitler, Emily

Subjects
Cardiac resynchronization therapy, Conduction system pacing, Guideline, His bundle pacing, Left bundle branch area pacing, Child, Humans, Bundle of His, Treatment Outcome, Cardiac Conduction System Disease, Cardiac Resynchronization Therapy, Heart Failure, Electrocardiography
Abstract

Cardiac physiologic pacing (CPP), encompassing cardiac resynchronization therapy (CRT) and conduction system pacing (CSP), has emerged as a pacing therapy strategy that may mitigate or prevent the development of heart failure (HF) in patients with ventricular dyssynchrony or pacing-induced cardiomyopathy. This clinical practice guideline is intended to provide guidance on indications for CRT for HF therapy and CPP in patients with pacemaker indications or HF, patient selection, pre-procedure evaluation and preparation, implant procedure management, follow-up evaluation and optimization of CPP response, and use in pediatric populations. Gaps in knowledge, pointing to new directions for future research, are also identified.

Published
2023

4. Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial

Author

Fujiki, Shinya, Iijima, Kenichi, Nakagawa, Yoshihisa, Takahashi, Kazuyoshi, Okabe, Masaaki, Kusano, Kengo, Owada, Shingen, Kondo, Yusuke, Tsujita, Kenichi, Shimizu, Wataru, Tomita, Hirofumi, Watanabe, Masaya, Shoda, Morio, Watanabe, Masafumi, Tokano, Takashi, Murohara, Toyoaki, Kaneshiro, Takashi, Kato, Takeshi, Hayashi, Hidemori, Maemura, Koji, Niwano, Shinichi, Umemoto, Tomio, Yoshida, Hisako, Ota, Keiko, Tanaka, Takahiro, Kitamura, Nobutaka, Node, Koichi, and Minamino, Tohru

Published
2024
Full Text
View/download PDF

7. Safety, efficacy, and reliability evaluation ofa novel small-diameter defibrillation lead: Global LEADR pivotal trial results

Author

Sanders, Prashanthan, Pathak, Rajeev, Denman, Russell Allen, Mihalcz, Attila, Philippon, Francois, Tsang, Bernice, Sumner, Glenn, Chen, Minglong, Han, Xiuebin, Liu, Xingbin, Philbert, Berit Thornvig, Defaye, Pascal, Anselme, Frederic, Stellbrink, Christoph, Chan, Ngai-Yin, Tse, Hung-Fat, De Filippo, Paolo, Ando, Kenji, Kusano, Kengo, Shoda, Morio, Khelae, Surinder Kaur, Lopes do Carmo, Pedro Miguel, Milasinovic, Goran, Boey, Elaine, Anguera Camos, Ignasi, Cano Pérez, Oscar, Whinnett, Zachary, Baranowski, Bryan, Friedman, Meir, Dinerman, Jay, Schaller, Robert, Bozorgnia, Babak, Zakaib, John, Chinitz, Jason, West, Michael, Ramza, Brian, Canby, Robert, Takata, Theodore, Shah, Maully, Winner, Marshall, Wilson, David, Mason, Pamela, Richardson, Travis, Kalahasty, Gautham, Sholevar, Darius, Smith, Timothy, Crossley, George H., III, Hansky, Bert, Shah, Maully J., Richardson, Travis D., Philippon, François, Zakaib, John S., Sholevar, Darius P., Pathak, Rajeev K., Milašinović, Goran, Chinitz, Jason S., West, Michael B., Ramza, Brian M., Han, Xuebin, Carta, Roberto, Geelen, Tessa, Himes, Adam K., Platner, Megan L., Thompson, Amy E., and Mason, Pamela K.

Published
2024
Full Text
View/download PDF

10. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure

Author

Chung, Mina K., Patton, Kristen K., Lau, Chu-Pak, Dal Forno, Alexander R.J., Al-Khatib, Sana M., Arora, Vanita, Birgersdotter-Green, Ulrika Maria, Cha, Yong-Mei, Chung, Eugene H., Cronin, Edmond M., Curtis, Anne B., Cygankiewicz, Iwona, Dandamudi, Gopi, Dubin, Anne M., Ensch, Douglas P., Glotzer, Taya V., Gold, Michael R., Goldberger, Zachary D., Gopinathannair, Rakesh, Gorodeski, Eiran Z., Gutierrez, Alejandra, Guzman, Juan C., Huang, Weijian, Imrey, Peter B., Indik, Julia H., Karim, Saima, Karpawich, Peter P., Khaykin, Yaariv, Kiehl, Erich L., Kron, Jordana, Kutyifa, Valentina, Link, Mark S., Marine, Joseph E., Mullens, Wilfried, Park, Seung-Jung, Parkash, Ratika, Patete, Manuel F., Pathak, Rajeev Kumar, Perona, Carlos A., Rickard, John, Schoenfeld, Mark H., Seow, Swee-Chong, Shen, Win-Kuang, Shoda, Morio, Singh, Jagmeet P., Slotwiner, David J., Sridhar, Arun Raghav M., Srivatsa, Uma N., Stecker, Eric C., Tanawuttiwat, Tanyanan, Tang, W.H. Wilson, Tapias, Carlos Andres, Tracy, Cynthia M., Upadhyay, Gaurav A., Varma, Niraj, Vernooy, Kevin, Vijayaraman, Pugazhendhi, Worsnick, Sarah Ann, Zareba, Wojciech, and Zeitler, Emily P.

Published
2023
Full Text
View/download PDF

13. The Value of Programmed Ventricular Extrastimuli From the Right Ventricular Basal Septum During Supraventricular Tachycardia

Author

Higuchi, Satoshi, Ito, Hiroyuki, Gerstenfeld, Edward P., Lee, Adam C., Lee, Byron K., Marcus, Gregory M., Hsia, Henry H., Moss, Joshua D., Lee, Randall J., Dewland, Thomas A., Vedantham, Vasanth, Tseng, Zian H., Patel, Akash R., Tanel, Ronn E., Badhwar, Nitish, Pellegrini, Cara N., Kawamura, Mitsuharu, Shoda, Morio, Hwang, Chun, Refaat, Marwan M., and Scheinman, Melvin M.

Published
2023
Full Text
View/download PDF

16. Microporous polysaccharide hemospheres for reducing pocket hematomas after cardiac device implantation in patients on antithrombotic therapy.

Author

Matsui, Yuko, Higuchi, Satoshi, Mori, Fumiaki, Takehisa, Kao, Kikuchi, Kensuke, Kikuchi, Haruka, Hirobe, Kohei, Maeda, Ryozo, Tsukamoto, Kei, Saito, Takashi, Shoda, Morio, and Yamaguchi, Junichi

Subjects
PREVENTION of surgical complications, WARFARIN, RISK assessment, HEMOSTATICS, ANTICOAGULANTS, SCIENTIFIC observation, HEMATOMA, RETROSPECTIVE studies, FIBRINOLYTIC agents, MULTIVARIATE analysis, DESCRIPTIVE statistics, POLYSACCHARIDES, KAPLAN-Meier estimator, IMPLANTABLE cardioverter-defibrillators, STATISTICS, CARDIAC pacemakers, CARDIAC pacing, COMPARATIVE studies, PLATELET aggregation inhibitors, CONFIDENCE intervals, PROPORTIONAL hazards models, DISEASE risk factors
Abstract

Background: Various surgical procedures have employed microporous polysaccharide hemosphere (MPH) hemostatic agents. However, data regarding their effectiveness in preventing pocket hematomas (PHs) during the implantation of cardiac implantable electronic devices (CIED) among the Asian population are limited. Therefore, this study aimed to investigate the potential benefits of using MPH hemostatic agents during CIED implantations as a preventive measure against post‐procedural PHs. Methods: We conducted a retrospective, single‐center, observational study involving 255 consecutive Japanese patients who underwent CIED implantation between November 2017 and April 2021. We compared PH occurrences within 28 days after CIED implantation between patients who received MPH hemostatic agents (n = 145) and those who did not (n = 110). Results: PH development was observed in nine (6.2%) patients who received MPH hemostatic agents and in 13 (11.8%) patients without MPH hemostatic (p =.111). Kaplan–Meier analysis of PH development revealed no significant difference between the two groups (log‐rank p =.102). However, utilizing MPH hemostatic agents among patients taking antithrombotic drugs, including antiplatelet medications, direct oral anticoagulants, and warfarin, significantly reduced PH incidence (log‐rank p =.03). The multivariate Cox proportional hazards model demonstrated that MPH hemostatic agent utilization independently correlated with a decreased PH risk (hazard ratio 0.22, 95% confidence interval 0.08–0.63, p =.004). Conclusions: The findings of this study suggest that the incorporation of MPH hemostatic agents into standard practice may benefit to mitigate PH risk during CIED implantations in patients on antithrombotic therapy. This simple and practical measure may be valuable, especially in high‐risk patients, such as those taking antithrombotic medications. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. Outcome of transvenous lead extraction in nonagenarians: A single‐center retrospective study.

Author

Komatsu, Toshinori, Okada, Ayako, Shoda, Morio, Tanaka, Kiu, Kobayashi, Hideki, Oguchi, Yasutaka, Saigusa, Tatsuya, Ebisawa, Soichiro, Motoki, Hirohiko, and Kuwahara, Koichiro

Subjects
PROSTHESIS-related infections, NONAGENARIANS, MEDICAL device removal, TREATMENT effectiveness, RETROSPECTIVE studies, DESCRIPTIVE statistics, IMPLANTABLE cardioverter-defibrillators, DATA analysis software, OLD age
Abstract

Background: Transvenous lead extraction (TLE) for cardiovascular implantable electronic device (CIED)‐related infections has increased. The incidence of TLE in nonagenarians is low, with limited reports outlining the outcomes of this procedure. Therefore, in this study, we aimed to clarify the outcomes of TLE in nonagenarians. Methods: Patients with TLE treated at our hospital between 2014 and 2023 were retrospectively examined; patient characteristics, device type, indications, procedures, complications, and clinical data of nonagenarians were analyzed. Results: Of 12 patients with 24 leads (active fixation lead, n = 11; passive fixation lead, n = 13) who underwent TLE, the indication for TLE was infection (pocket infection, n = 8; sepsis, n = 4). Methicillin‐resistant Staphylococcus epidermidis was the most frequently identified causative agent (n = 4). The median patient age was 91 years; five patients were female. The median lead dwell time was 9 years. Excimer laser sheath (16 leads), mechanical sheath (five leads), Evolution RL (one lead), and manual traction (two leads) were employed in TLE. The procedure was successful in all patients, and only one had a minor complication. Six patients required CIED re‐implantation, and leadless pacemakers were selected for five patients. The 30‐day mortality after TLE was 0%. Conclusion: TLE can be safely performed in nonagenarians. The decision to perform TLE should not be based on old age alone; the suitability of removing infected CIEDs should be determined based on each patient's condition. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Novel Diagnostic Observations of Nodoventricular/Nodofascicular Pathway-Related Orthodromic Reciprocating Tachycardia Differentiating From Atrioventricular Nodal Re-Entrant Tachycardia

Author

Nagashima, Koichi, Kaneko, Yoshiaki, Maruyama, Mitsunori, Nogami, Akihiko, Kowase, Shinya, Mori, Hitoshi, Sumitomo, Naokata, Fukamizu, Seiji, Hojo, Rintaro, Kitamura, Takeshi, Soejima, Kyoko, Ueda, Akiko, Otsuka, Takayuki, Takami, Mitsuru, Tanimoto, Kojiro, Asakawa, Tetsuya, Kumagai, Kenta, Tamura, Shuntaro, Hasegawa, Hiroshi, Ogura, Kazuyoshi, Kawamura, Mitsuharu, Munetsugu, Yumi, Shoda, Morio, Higuchi, Satoshi, Kanazawa, Hisanori, Kusa, Shigeki, Mizukami, Akira, Miyazaki, Shinsuke, Wakamatsu, Yuji, and Okumura, Yasuo

Published
2020
Full Text
View/download PDF

34. Multicenter prospective observational study to clarify the current status and clinical outcome in Japanese patients who have an indication for implantable cardioverter defibrillator (ICD) or wearable cardioverter defibrillator (WCD) (TRANSITION JAPAN‐ICD/WCDstudy): Rationale and design of a prospective, multicenter, observational, comparative study

Author

Ikeya, Yukitoshi, Okumura, Yasuo, Kogawa, Rikitake, Nagashima, Koichi, Nakai, Toshiko, Yokoyama, Katsuaki, Iso, Kazuki, Kato, Takeshi, Tsuda, Toyonobu, Tachibana, Eizo, Hayashida, Satoshi, Fukaya, Hidehira, Ishizue, Naruya, Hayashi, Hidemori, Kuroda, Shunsuke, Sonoda, Kazumasa, Nakahara, Shiro, Hori, Yuichi, Harada, Masahide, Murakami, Masato, Iwasaki, Yu‐Ki, Aizawa, Yoshiyasu, Shimizu, Wataru, Fukamizu, Seiji, Takami, Mitsuru, Kusano, Kengo, Ishibashi, Kohei, Harada, Tomoo, Nakajima, Ikutaro, Tabuchi, Haruna, Kunimoto, Mitsuhiro, Shoda, Morio, Higuchi, Satoshi, Morishima, Itsuro, Kanzaki, Yasunori, Kato, Ritsushi, Ikeda, Yoshifumi, Makimoto, Hisaki, Kabutoya, Tomoyuki, Kario, Kazuomi, Arimoto, Takanori, Ninomiya, Yuichi, Yoshimoto, Issei, Sasaki, Shingo, Kondo, Yusuke, Chiba, Toshinori, Yamashita, Kennosuke, Mizuno, Yosuke, Inoue, Masaru, Ueyama, Takeshi, Koyama, Jyunjiro, Tsurugi, Takuo, Orita, Yoshiya, Asano, Taku, Shinke, Toshiro, Tanno, Kaoru, and Murotani, Kenta

Abstract

Despite the positive impact of implantable cardioverter defibrillators (ICDs) and wearable cardioverter defibrillators (WCDs) on prognosis, their implantation is often withheld especially in Japanese heart failure patients with reduced left ventricular ejection fraction (HFrEF) who have not experienced ventricular tachycardia (VT) or ventricular fibrillation (VF) for uncertain reasons. Recent advancements in heart failure (HF) medications have significantly improved the prognosis for HFrEF. Given this context, a critical reassessment of the treatment and prognosis of ICDs and WCDs is essential, as it has the potential to reshape awareness and treatment strategies for these patients. We are initiating a prospective multicenter observational study for HFrEF patients eligible for ICD in primary and secondary prevention, and WCD, regardless of device use, including all consenting patients. Study subjects are to be enrolled from 31 participant hospitals located throughout Japan from April 1, 2023, to December 31, 2024, and each will be followed up for 1 year or more. The planned sample size is 651 cases. The primary endpoint is the rate of cardiac implantable electronic device implementation. Other endpoints include the incidence of VT/VF and sudden death, all‐cause mortality, and HF hospitalization, other events. We will collect clinical background information plus each patient's symptoms, Clinical Frailty Scale score, laboratory test results, echocardiographic and electrocardiographic parameters, and serial changes will also be secondary endpoints. Not applicable. This study offers invaluable insights into understanding the role of ICD/WCD in Japanese HF patients in the new era of HF medication. The TRANSITION JAPAN‐ICD/WCD study explores the clinical outcomes of Japanese HFrEF patients meeting implantable cardioverter defibrillator (ICD) and wearable cardioverter defibrillator (WCD) criteria, including those who choose or decline device implantation, to assess the ICD/WCD current status after the introduction of new heart failure drugs like SGLT2i or ARNi in Japan.

Published
2024
Full Text
View/download PDF

35. Safety and Performance of the Micra VR Leadless Pacemaker in a Japanese Cohort ― Comparison With Global Studies ―

Author

Ando, Kenji, primary, Inoue, Kanki, additional, Harada, Tomoo, additional, Shizuta, Satoshi, additional, Yoshida, Yukihiko, additional, Kusano, Kengo, additional, Onuki, Tatsuya, additional, Watari, Yuji, additional, Fukui, Akio, additional, Sasaki, Shingo, additional, Shoda, Morio, additional, Nishii, Nobuhiro, additional, Shiose, Akira, additional, Hosoda, Junya, additional, Okai, Chie, additional, Stromberg, Kurt, additional, Murphy, Jeffrey, additional, Holmes, Thomas R, additional, and Soejima, Kyoko, additional

Published
2023
Full Text
View/download PDF

40. A mutually communicable external system resource in remote monitoring for cardiovascular implantable electronic devices.

Author

Hasumi, Eriko, Fujiu, Katsuhito, Nakamura, Kentaro, Yumino, Dai, Nishii, Nobuhiro, Imai, Yasushi, Shoda, Morio, and Komuro, Issei

Subjects
CARDIOVASCULAR disease treatment, PATIENT monitoring equipment, ELECTRODES, MEDICAL quality control, PILOT projects, COMPUTER networks, IMPLANTABLE cardioverter-defibrillators, ARTIFICIAL intelligence, ARTIFICIAL implants, INDIVIDUALIZED medicine, ACCURACY, WORKFLOW, PATIENT monitoring, CARDIAC pacing, RISK assessment, RESEARCH funding, INFORMATION resources, DATA analytics, CARDIAC pacemakers, DATA analysis software, TELEMEDICINE, ALGORITHMS, LONGITUDINAL method, ELECTRONICS
Abstract

Background: Using third‐party resources to manage remote monitoring (RM) data from implantable cardiac electronic devices (CIEDs) can assist in device clinic workflows. However, each hospital‐acquired data is not used for further analysis as big data. Methods and results: We developed a real‐time and automatically centralized system of CIED information from multiple hospitals. If the extensive data‐based analysis suggests individual problems, it can be returned to each hospital. To show its feasibility, we prospectively analyzed data from six hospitals. For example, unexpected abnormal battery levels were easily illustrated without recall information. Conclusions: The centralized RM system could be a new platform that promotes the utilization of device data as big data, and that information could be used for each patient's practice. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

43. 2023 HRS / APHRS / LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure

Author

Chung, Mina K., primary, Patton, Kristen K., additional, Lau, Chu‐Pak, additional, Dal Forno, Alexander R. J., additional, Al‐Khatib, Sana M., additional, Arora, Vanita, additional, Birgersdotter‐Green, Ulrika Maria, additional, Cha, Yong‐Mei, additional, Chung, Eugene H., additional, Cronin, Edmond M., additional, Curtis, Anne B., additional, Cygankiewicz, Iwona, additional, Dandamudi, Gopi, additional, Dubin, Anne M., additional, Ensch, Douglas P., additional, Glotzer, Taya V., additional, Gold, Michael R., additional, Goldberger, Zachary D., additional, Gopinathannair, Rakesh, additional, Gorodeski, Eiran Z., additional, Gutierrez, Alejandra, additional, Guzman, Juan C., additional, Huang, Weijian, additional, Imrey, Peter B., additional, Indik, Julia H., additional, Karim, Saima, additional, Karpawich, Peter P., additional, Khaykin, Yaariv, additional, Kiehl, Erich L., additional, Kron, Jordana, additional, Kutyifa, Valentina, additional, Link, Mark S., additional, Marine, Joseph E., additional, Mullens, Wilfried, additional, Park, Seung‐Jung, additional, Parkash, Ratika, additional, Patete, Manuel F., additional, Pathak, Rajeev Kumar, additional, Perona, Carlos A., additional, Rickard, John, additional, Schoenfeld, Mark H., additional, Seow, Swee‐Chong, additional, Shen, Win‐Kuang, additional, Shoda, Morio, additional, Singh, Jagmeet P., additional, Slotwiner, David J., additional, Sridhar, Arun Raghav M., additional, Srivatsa, Uma N., additional, Stecker, Eric C., additional, Tanawuttiwat, Tanyanan, additional, Tang, W. H. Wilson, additional, Tapias, Carlos Andres, additional, Tracy, Cynthia M., additional, Upadhyay, Gaurav A., additional, Varma, Niraj, additional, Vernooy, Kevin, additional, Vijayaraman, Pugazhendhi, additional, Worsnick, Sarah Ann, additional, Zareba, Wojciech, additional, and Zeitler, Emily P., additional

Published
2023
Full Text
View/download PDF

44. A Dual-Chamber Leadless Pacemaker

Author

Knops, Reinoud E., primary, Reddy, Vivek Y., additional, Ip, James E., additional, Doshi, Rahul, additional, Exner, Derek V., additional, Defaye, Pascal, additional, Canby, Robert, additional, Bongiorni, Maria Grazia, additional, Shoda, Morio, additional, Hindricks, Gerhard, additional, Neužil, Petr, additional, Rashtian, Mayer, additional, Breeman, Karel T.N., additional, Nevo, Jordan R., additional, Ganz, Leonard, additional, Hubbard, Chris, additional, and Cantillon, Daniel J., additional

Published
2023
Full Text
View/download PDF

45. LB-456640-1 PERCUTANEOUS IMPLANTATION OF A DUAL CHAMBER LEADLESS CARDIAC PACEMAKER SYSTEM WITH BIDIRECTIONAL COMMUNICATION FOR ATRIOVENTRICULAR SYNCHRONY

Author

Cantillon, Daniel J., primary, Reddy, Vivek Y., additional, Ip, James E., additional, Doshi, Rahul N., additional, Exner, Derek V., additional, Defaye, Pascal, additional, Canby, Robert C., additional, Bongiorni, Maria Grazia, additional, Shoda, Morio, additional, Hindricks, Gerhard, additional, Neuzil, Petr, additional, Rashtian, Mayer, additional, Breeman, Karel, additional, Nevo, Jordan, additional, Ganz, Leonard, additional, Hubbard, Chris, additional, and Knops, Reinoud, additional

Published
2023
Full Text
View/download PDF

50. Registry for Evaluating Healthy Life Expectancy and Long-Term Outcomes after Catheter Ablation of Atrial Fibrillation in the Very Elderly (REHEALTH AF) study: rationale and design of a prospective, multicentre, observational, comparative study

Author

Okumura, Yasuo, primary, Nagashima, Koichi, additional, Watanabe, Ryuta, additional, Yokoyama, Katsuaki, additional, Kato, Takeshi, additional, Fukaya, Hidehira, additional, Hayashi, Hidemori, additional, Nakahara, Shiro, additional, Shimizu, Wataru, additional, Iwasaki, Yu-ki, additional, Fujimoto, Yuhi, additional, Mukai, Yasushi, additional, Ejima, Koichiro, additional, Otsuka, Takayuki, additional, Suzuki, Shinya, additional, Murakami, Masato, additional, Kimura, Masaomi, additional, Harada, Masahide, additional, Koyama, Junjiroh, additional, Okamatsu, Hideharu, additional, Yamane, Teiichi, additional, Yamashita, Seigo, additional, Tokuda, Michifumi, additional, Narui, Ryohsuke, additional, Takami, Mitsuru, additional, Shoda, Morio, additional, Harada, Tomoo, additional, Nakajima, Ikutaro, additional, Fujiu, Katsuhito, additional, Hiroshima, Kenichi, additional, Tanimoto, Kojiro, additional, Fujino, Tadashi, additional, Nakamura, Keijiro, additional, Kumagai, Koji, additional, Okada, Ayako, additional, Kobayashi, Hideki, additional, Hayashi, Tatsuya, additional, Watari, Yuji, additional, Hatsuno, Mina, additional, Tachibana, Eizo, additional, Iso, Kazuki, additional, Sonoda, Kazumasa, additional, Aizawa, Yoshiyasu, additional, Chikata, Akio, additional, Sakagami, Satoru, additional, Inoue, Masaru, additional, Minamiguchi, Hitoshi, additional, Makino, Nobuhiko, additional, Satomi, Kazuhiro, additional, Yazaki, Yoshinao, additional, Aoyagi, Hideshi, additional, Ichikawa, Makoto, additional, Haruta, Hironori, additional, Hiro, Takafumi, additional, Okubo, Kimie, additional, Arima, Ken, additional, Tojo, Taiki, additional, Kihara, Hajime, additional, Miyanaga, Satoru, additional, Fukuda, Yoshiaki, additional, Oiwa, Koji, additional, Fujiishi, Tamami, additional, Akabane, Masashi, additional, Ishikawa, Norikazu, additional, Kusano, Kengo, additional, Miyamoto, Koji, additional, Tabuchi, Haruna, additional, Shiozawa, Tomoyuki, additional, Miyamoto, Kenjiro, additional, Mase, Hiroshi, additional, and Murotani, Kenta, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results